Details of the Drug

General Information of Drug (ID: DMHEQQL)

Drug Name

Dalotuzumab

Synonyms

AC1MHYZY; SCHEMBL4534994; BDBM82422; NSC_3035240; CAS_109872-41-5; D06396; L000945; 4-amino-N-(1-azabicyclo[3.3.1]nonan-4-yl)-5-chloro-2-methoxybenzamide

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

Cross-matching ID

TTD ID: D04BOT

References

1	ClinicalTrials.gov (NCT01605396) A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064). U.S. National Institutes of Health.